Summary
In our recent report we observed the abnormal response to PHA stimulation in the peripheral lymphocytes of patients with chronic liver diseases.
The present report concerns extensive studies of this earlier report; analysis of the subpopulation and function of peripheral lymphocytes in patients with liver diseases. PHA responsiveness in acute hepatitis was reduced in the acute phase and improved during the convalescent stage. In chronic liver disease, half of the patients showed a decrease in T-cell population as well as a reduced response to PHA stimulation. These phenomena were observed more frequently in HBs-antigen positive patients than in HBs-antigen negative cases. Furthermore, we found the existence of an inhibitor to PHA response in the serum of 8 cases among 19 patients with various liver diseases. In patients with such a serum inhibitor, the reactivity of the lymphocyte itself to PHA was considerably higher but the T-cell population was much more decreased than that of inhibitor negative cases.
Similar content being viewed by others
References
Blumberg, B.S., Sutnick, A.I. and London, W.T.: Australia antigen as a hepatitis virus. Am. J. Med. 48: 1–8, 1970.
Almeida, J.D. and Waterson, A.P.: Immune complexes in hepatitis. Lancet 2: 983–986, 1969.
Dudley, F.J. and Fox, R.A.: Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet 1: 723–726, 1972.
Yeung, L.A.A.C.: Lymphocyte transformation by Australia antigen. Lancet 2: 470–471, 1971.
Popper, H. and Mackay, I.R.: Relation between Australia antigen and autoimmune hepatitis. Lancet 1: 1161–1163, 1972.
Yamamoto, S., Monna, T., Enomoto, T., et al.: Hepatitis as autoimmune disease: liver cell damage by immune reaction related to HBs-antigen. J. Clin. Sci. (Osaka) 9: 313–321, 1973.
Smetana, H.: The histopathology of viral hepatitis by needle biopsy. Gastroenterology 26: 612–625, 1954.
Böyum, A.: Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21: Suppl. 97, 77–89, 1968.
Lay, W.H., Mendes, N.F., Bianco, C. and Nussenzweig, V.: Binding of sheep red blood cells to a large population of human lymphocytes. Nature 230: 531–532, 1971.
Silveira, N.P.A., Mendes, N.F. and Tolnai, M.E.A.: Tissue localization of two populations of human lymphocytes distinguished by membrane receptors. J. Immunol. 108: 1456–1460, 1972.
Grey, H.M., Rabellino, E. and Pirofsky, B.: Immunoglobulins on the surface of lymphocytes. J. Clin. Invest. 50: 2368–2375, 1971.
Papamichail, M., Brown, J.C. and Holborow, E.J.: Immunoglobulins on the surface of human lymphocytes. Lancet 2: 850–852, 1971.
Jondal, M., Holm, G. and Wigzell, H.: Surface markers T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosetts with sheep red cells. J. Exp. Med. 136: 207–215. 1972.
Minowada, J., Ohnuma, T. and Moore, G.E.: Rosette-forming human lymphoid cell lines; 1. Establishment and evidence for origin of thymusderived lymphocytes. J. Nat. Can. Inst. 49: 891–895, 1972.
Wybran, J. and Fudenberg, H.H.: Thymusderived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections and other diseases. J. Clin. Invest. 52: 1026–1032, 1973.
Whittingham, S. and Mackay, I.R.: Rosette formation by human thymocytes. Cell. Immunol. 6: 362–367, 1973.
Duklim, S., Kiszkiss, D.F., Jacobson, R.R., Choi, Y.S. and Good, R.A.: Thymus-dependent lymphocytes of peripheral blood in leprosy patients. Infect. Immun. 9: 394–399, 1974.
Aiuti, F., Ciaria, M.V., D’Asero, C, D’Amelio, R. and Garofalo, J.A.: Surface markers on lymphocytes of patients with infectious diseases. Infect. Immun. 8: 110–117, 1973.
DeHoratius, R.J., Strickland, R.G. and Williams, Jr. R.C.: T and B lymphocyte in Acute and Chronic Hepatitis. Clin. Immunol. Immunopathol. 2: 353–360, 1974.
Aisenberg, A.C. and Bloch, K.J.: Immunoglobulins on the surface on neoplastic lymphocytes. New Eng. J. Med. 287: 272–276, 1972.
Cohnen, G., Augener, W., Brittinger, G.and Douglas, S.D.: Rosette-forming lymphocytes in Hodgkin’s disease. New Eng. J. Med. 289: 863, 1973.
Williams, R.C., DeBord, J.R., Mellbye, O.J., Messner, R.P. and Lindström, F.J.: Studies of T-and B-lymphocytes in patients with connective tissue disease. J. Clin. Invest. 52: 283–295, 1973.
Bernstein, I.M., Webster, K.H., Williams, Jr. R.C. and Strickland, R.G.: Reduction in circulating T lymphocytes in alcoholic liver disease. Lancet 2: 488–490, 1974.
Niklasson, P.M. and Williams, Jr. R.C: Studies of peripheral blood T and B-lymphocytes in acute infections. Infect. Immun. 9: 1–7, 1974.
Silk, M.R.: The effect of uremic plasma on lymphocyte transformation. Invest. Urol. 5: 195–199, 1967.
Sample, W.F., Gertner, H.R. and Chretien, P.B.: Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma. J. Nat. Cancer Inst. 46: 1291–1297, 1971.
Suciu-Foca, N., Buda, J., MacManus, J., Thiem, T. and Reemtsma, K.: Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer. Cancer Res. 33: 2373–2377, 1973.
Trubowitz, S., Masek, B. and Del Rosario, A.: Lymphocyte response to phytohemagglutinin in Hodgkin’s disease, lymphocytic leukemia and leukosarcoma. Cancer 19: 2019–2023, 1966.
Levene, G.H., Turk, J.L., Wright, D.J.M. and Grimble, A.G.S.: Reduced lymphocyte transformation due to plasma factor in patients with active syphilis. Lancet 2: 246–247, 1969.
Knowels, M., Hughes, D., Caspany, E.A. and Field, E.J.: Lymphocyte transformation in multiple sclerosis: inhibition of unstimulated thymidine uptake by a serum factor. Lancet 2: 1207–1208, 1968.
Belcher, R.W., Carney, J.F. and Nankervis, G.A.: Effect of sera from patients with sarcoidosis on in vitro lymphocyte response. Int. Arch. Allergy 46: 183–190, 1974.
Newberry, W.M., Shorey, J.W., Sanford, J.P. and Combes, B.: Depression of lymphocyte reactivity to phytohemagglutinin by serum from patients with liver disease. Cell. Immunol. 5: 87–97, 1973.
Macsween, R.N.M. and Thomas, M.A.: Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein dervivative (PPD) in primary biliary cirrhosis. Clin. Exp. Immunol. 15: 523–533, 1973.
Hsu, CCS. and Leevy, CM.: Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis. Clin. Exp. Immunol. 8: 749–760, 1971.
Mowbray, J.F.: Ability of large doses of an alpha plasma protein fraction to inhibit antibody production. Immunol. 6: 217–225, 1963.
Mannick, J.A. and Schmid, K.: Prolongation of allograft survival by an alpha globulin isolated from normal blood. Transplantation 5: 1231–1238, 1967.
Occhino, J.C., Glasgow, A.H., Cooperband, S.R., Mannick, J.A. and Schmid, K.: Isolation of an immunosuppressive peptide fraction from human plasma. J. Immunol. 110: 685–694, 1973.
Ayoub, J. and Kasakwa, S.: In vitro response of foetal lymphocytes to PHA and a foetal plasma which suppresses the PHA response of adult lymphocytes. Clin. Exp. Immunol. 8: 427–437, 1971.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakao, M., Mizoguchi, Y., Monna, T. et al. Studies on the subpolulation and function of peripheral lymphocytes, and inhibitor to pha stimulation existing in the serum of patients with liver disease. Gastroenterol Jpn 10, 307–315 (1975). https://doi.org/10.1007/BF02776361
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02776361